<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Ontario Bioscience Industry Organization &#187; obio</title>
	<atom:link href="http://obio.ca/tag/obio/feed/" rel="self" type="application/rss+xml" />
	<link>http://obio.ca</link>
	<description>Ontario&#039;s leading advocate for the life sciences sector</description>
	<lastBuildDate>Mon, 12 Mar 2012 00:32:42 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Ontario&#8217;s Bioscience Industry &#8211; Translating Strategy into Action</title>
		<link>http://obio.ca/2011/05/ontarios-bioscience-industry-translating-strategy-into-action/</link>
		<comments>http://obio.ca/2011/05/ontarios-bioscience-industry-translating-strategy-into-action/#comments</comments>
		<pubDate>Fri, 27 May 2011 22:41:57 +0000</pubDate>
		<dc:creator>obio</dc:creator>
				<category><![CDATA[Featured Articles]]></category>
		<category><![CDATA[access to capital]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[obio]]></category>

		<guid isPermaLink="false">http://obio.ca/?p=624</guid>
		<description><![CDATA[The Ontario Bioscience Industry Organization (OBIO) works to advance the development and growth of a sustainable, commercially &#8211; driven, life sciences industry in Ontario. OBIO is a private sector, membership-based organization representing Ontario’s human-health bioscience industry.
Key among Ontario&#8217;s bioscience strengths are a pipeline of high value, early stage intellectual property and start-up opportunities. In addition, [...]]]></description>
			<content:encoded><![CDATA[<p>The Ontario Bioscience Industry Organization (OBIO) works to advance the development and growth of a sustainable, commercially &#8211; driven, life sciences industry in Ontario. OBIO is a private sector, membership-based organization representing Ontario’s human-health bioscience industry.</p>
<p>Key among Ontario&#8217;s bioscience strengths are a pipeline of high value, early stage intellectual property and start-up opportunities. In addition, Ontario boasts a strong academic research base with significant investment in intellectual-property generation and research training.</p>
<p>Ontario’s human health bioscience industry consists of almost 100 small and medium-size companies of which over 50 per cent are working on therapeutic products. Forty per cent of companies are located in the Greater Toronto Area with access to eight universities, 10 colleges, 60 hospitals and an innovative business incubator (MaRS Discovery District)&#8230;   [more]</p>
<p>Click here to <a href="http://obio.ca/wp-content/uploads/2011/05/Ontarios-Bioscience-Industry.pdf">view the full article </a> in PDF format, by Gail Garland in <em>Vantage GTA, Spring Summer 2011</em>.</p>
]]></content:encoded>
			<wfw:commentRss>http://obio.ca/2011/05/ontarios-bioscience-industry-translating-strategy-into-action/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Leveraging the $7 Million Fund &#8211; Designated for Ontario Bioscience Companies Announced in May 2010</title>
		<link>http://obio.ca/2011/05/leveraging-the-7-million-fund-designated-for-ontario-bioscience-companies-announced-in-may-2010/</link>
		<comments>http://obio.ca/2011/05/leveraging-the-7-million-fund-designated-for-ontario-bioscience-companies-announced-in-may-2010/#comments</comments>
		<pubDate>Fri, 27 May 2011 21:09:51 +0000</pubDate>
		<dc:creator>obio</dc:creator>
				<category><![CDATA[Featured Articles]]></category>
		<category><![CDATA[access to capital]]></category>
		<category><![CDATA[biotechnology industry]]></category>
		<category><![CDATA[government of ontario]]></category>
		<category><![CDATA[obio]]></category>

		<guid isPermaLink="false">http://obio.ca/?p=606</guid>
		<description><![CDATA[During the fall of 2009, with Ontario’s bioscience industry fighting for survival due to an inability to raise capital in the midst of a world-wide economic crisis, OBIO mobilized industry CEOs to take action. With a sense of urgency derived from the need for a plan to ensure the survival of the industry, OBIO organized [...]]]></description>
			<content:encoded><![CDATA[<p>During the fall of 2009, with Ontario’s bioscience industry fighting for survival due to an inability to raise capital in the midst of a world-wide economic crisis, OBIO mobilized industry CEOs to take action. With a sense of urgency derived from the need for a plan to ensure the survival of the industry, OBIO organized its first province-wide consultation process ultimately generating a set of recommendations for industry survival and growth.  These recommendations were provided to the Ontario provincial government and detailed changes to existing provincial capital and tax programs which when implemented would have a positive impact on biotech companies&#8230; </p>
<p>Click here to <a href="http://obio.ca/wp-content/uploads/2011/05/Leveraging-the-7-Million.pdf">download a PDF version of the full article</a>, by Gail Garland, as published in <em>Biotechnology Focus, May 2011</em>.</p>
]]></content:encoded>
			<wfw:commentRss>http://obio.ca/2011/05/leveraging-the-7-million-fund-designated-for-ontario-bioscience-companies-announced-in-may-2010/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

